FDA Inspection 625877 — Carmen Diaz-Obregon M.D.

Carmen Diaz-Obregon M.D. — FEI 3007748931

The FDA completed an inspection of Carmen Diaz-Obregon M.D. on October 23, 2009 in Martin Lagos. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
October 23, 2009
Fiscal Year
2010
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Martin Lagos (Spain)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
753021 CFR 312.62(b)Case history records- inadequate or inadequate
756021 CFR 312.60FD-1572, protocol compliance